4.6 Review

Scientific Advances in Thoracic Oncology 2016

期刊

JOURNAL OF THORACIC ONCOLOGY
卷 12, 期 8, 页码 1183-1209

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2017.05.019

关键词

NSCLC; Malignant mesothelioma; SCLC; Smoking; cessation; Cancer prevention; Targeted therapy; Immunotherapy; Screening; Pathology; Staging; Surgery; Adjuvant therapy; Radiotherapy; Molecular diagnostics; Biomarkers; Value of therapy

资金

  1. Lung Cancer Foundation of America-International Association
  2. National Cancer Institute [CA090578]
  3. Cancer Research UK
  4. American Cancer Society [RSG 11-186]
  5. Grants-in-Aid for Scientific Research [16H05167] Funding Source: KAKEN
  6. Cancer Research UK [20465] Funding Source: researchfish

向作者/读者索取更多资源

Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review. (C) 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据